TrialEuropean radiology2018

CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial.

Matthias F Froelich et al.PubMed ↗Publisher ↗

No numbers read from the abstract.